Clinical Trial Update: Assessment of GVG for the Treatment of Methamphetamine Dependence [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating gamma-vinyl-GABA (GVG) for methamphetamine use disorder has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Methamphetamine Use Disorder

Drugs mentioned

• gamma-vinyl-GABA (gamma-vinyl-GABA)

Snippet

Sponsor: Baylor College of Medicine | Conditions: Methamphetamine Addiction | Phase 1 | Status: COMPLETED